Triple Antiviral Therapy Promising for Mild-to-Moderate COVID-19
Duration of viral shedding shorter with combination of lopinavir-ritonavir, ribavarin, interferon beta-1b
Hydroxychloroquine Has No Impact on Outcomes in COVID-19
No link seen between use of the drug and risk for composite end point of intubation or death
More Head Impacts Up Risk for Death in NFL Players
Findings based on cumulative head impact index scores and all-cause mortality
Death and Disability From Stroke Down in United Kingdom
Findings for both men and women and blacks and whites
Incidence of Psych Morbidity Up With Spinal Cord Injury
Prevalence of all chronic diseases, chronic disease multimorbidity also up with SCI except for HIV/AIDS
Previous Pregnancy Complication Ups Risk for Preterm Delivery
Any of five complications in a first term delivery may predict subsequent preterm delivery
ACE Inhibitor/ARB Use Not Tied to COVID-19 Test Positivity
No significant association identified in overlap propensity score weighting analysis
Risk for SARS-CoV-2 Lower for Prostate Cancer Patients on ADT
Risk reduced fourfold with androgen-deprivation therapy versus other treatment for prostate cancer
Symptomatic COVID-19 Infection Fatality Rate 1.3 Percent in U.S.
County-specific infection fatality rates for symptomatic cases varied from 0.5 to 3.6 percent
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
